Gene Logic to Patent Disease Genes in Deal With Life Technologies | GenomeWeb

GAITHERSBURG, Md.--Gene Logic said last week it would partner with a Rockville, Md., reagent company, Life Technologies, to fully sequence and file patents on 5 percent of the human genes that offer the “most promising gateways for new medicines against major diseases,” which have been identified using Gene Logic’s GeneExpress 200 database suite.


Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.